Fresh Approach to Clinical Trials: Perspective from India - Prof. Prafulla Kerkar

All credits: Prof. Prafulla Kerkar

A Conference Talk by:Prof. Prafulla Kerkar,Presented at: 8th PVRI Annual World Congress, Guangzhou, China

Additional keywords: clinical trials,India,regulation

Latest PVD abstracts from PubMed

Revealing the Grain Boundary Formation Mechanism and Kinetics during Polycrystalline MoS2 Growth.

Authors: Chen S, Gao J, Srinivasan BM, Zhang G, Yang M, Chai J, Wang S, Chi D, Zhang YW Source: ACS Appl Mater Interfaces

Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells.

Authors: Santos-Rebelo A, Kumar P, Pillay V, Choonara YE, Eleutério C, Figueira M, Viana AS, Ascensão L, Molpeceres J, Rijo P, Correia I, Amaral J, Solá S, Rodrigues CMP, Gaspar MM, Reis CP Source: Cancers (Basel)

Dense Glass Packing Can Slow Reactions with an Atmospheric Gas.

Authors: Qiu Y, Bieser ME, Ediger MD Source: J Phys Chem B

Revisiting the Reverse Sural Artery Flap in Distal Lower Extremity Reconstruction: A Systematic Review and Risk Analysis.

Authors: Daar DA, Abdou SA, David JA, Kirby DJ, Wilson SC, Saadeh PB Source: Ann Plast Surg

On manufacturing multilayer-like nanostructures using misorientation gradients in PVD films.

Authors: Avila PRT, da Silva EP, Rodrigues AM, Aristizabal K, Pineda F, Coelho RS, Garcia JL, Soldera F, Walczak M, Pinto HC Source: Sci Rep

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

Related Content

{{GlobalController.truncateTitle("Why Asia Offers Good Opportunities for Clinical Trials - Dr. Kevin Laliberte", 65)}}

{{GlobalController.truncateTitle("Lewis Rubin - Current Guidelines", 65)}}

{{GlobalController.truncateTitle("Majdy Idrees - Ensuring best quality of care in developing countries", 65)}}

{{GlobalController.truncateTitle("Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension ", 65)}}

{{GlobalController.truncateTitle(" Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension", 65)}}

Add to reading list

Share this content

Our research platform is the world.